NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics said on Tuesday it has acquired Path Labs for $6 million.

Doing business as Path Logic, Path Labs is headquartered in Santa Ana, Calif., and provides specialized anatomic pathology services to hospitals and physicians in Northern California. Its areas of expertise include renal pathology, dermapathology, women's health, and gastrointestinal and genitourinary pathology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.